Dew, I will be surprised if all of the companies you mention in your post, along with JNJ that is also active in joint therapy, do not find VCEL an attractive buyout candidate in light of its recently FDA-approved MACI technology---take a look.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.